Innovative pharmas gained 9% of sales with severe polarization
Last year, innovative pharmaceutical companies experienced an approximately 9% growth in sales, but reportedly had severe polarization in profitability.
Although general and foreign pharmaceutical companies had a great business performance, but most biopharmaceutical companies had a poor perform...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.